How We Treated a Kidney Transplant Recipient Who Was Receiving Sirolimus During the SARS-CoV-2 Pandemic? Primum Non Nocere

Authors : Hamad DHEİR, Didar ŞENOCAK, Savaş SİPAHİ, Yasemin GÜNDÜZ, Selcuk YAYLACI, Necattin FIRAT, Ahmed Bilal GENÇ, Mehmet KÖROĞLU, Oğuz KARABAY

Pages : 345-348

Doi:10.31832/smj.783277

View : 31 | Download : 9

Publication Date : 2022-06-30

Article Type : Other Papers

Abstract :The new Coronavirus SARS-CoV-2 insert ignore into journalissuearticles values(COVID-19); epidemic continues to affect the world. It is emphasized that COVID-19 is more severe in patients with solid organ transplantation, and the risk of mortality may be higher than in the normal population. Herein, with the first time, we described a COVID-19 pneumoniae kidney recipient case treated with sirolimus. A 49-year-old male patient had kidney transplantation 13 years ago. He was used prednisolone and sirolimus. His main complaints were fever insert ignore into journalissuearticles values(38.3°C); and weakness. Atypical pneumoniae was diagnosed with thorax computed tomography. The respiratory specimen of the patient was positive with COVID-19 by PCR test. Sirolimus was stopped due to the immunosuppressive effect, and the treatment switched to low dose everolimus. Also, hydroxychloroquine, oseltamivir and azithromycin triple therapy was started for five days. The patient was discharged with healing on the seventh day.
Keywords : COVID 19, Kidney transplantation, Sirolimus